1. Home
  2. KALA vs UCL Comparison

KALA vs UCL Comparison

Compare KALA & UCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KALA BIO Inc.

KALA

KALA BIO Inc.

HOLD

Current Price

$2.09

Market Cap

41.5M

Sector

Health Care

ML Signal

HOLD

Logo uCloudlink Group Inc.

UCL

uCloudlink Group Inc.

HOLD

Current Price

$1.09

Market Cap

40.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
KALA
UCL
Founded
2009
2014
Country
United States
Hong Kong
Employees
6
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
41.5M
40.0M
IPO Year
2017
2019

Fundamental Metrics

Financial Performance
Metric
KALA
UCL
Price
$2.09
$1.09
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$31.50
N/A
AVG Volume (30 Days)
767.7K
13.5K
Earning Date
04-15-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
67.39
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$11.60
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$13.72
Revenue Growth
N/A
N/A
52 Week Low
$0.07
$0.95
52 Week High
$20.58
$4.19

Technical Indicators

Market Signals
Indicator
KALA
UCL
Relative Strength Index (RSI) 53.67 45.49
Support Level $0.18 N/A
Resistance Level $3.96 $1.19
Average True Range (ATR) 0.26 0.08
MACD -0.12 0.01
Stochastic Oscillator 2.81 50.00

Price Performance

Historical Comparison
KALA
UCL

About KALA KALA BIO Inc.

Kala Bio Inc is a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of inventive therapies for rare and severe diseases of the front and back of the eye. It main product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

About UCL uCloudlink Group Inc.

Ucloudlink Group Inc is engaged in the provision of data connectivity services and sales of Wi-Fi terminals and data-related products globally. Its uCloudlink cloud SIM platform is designed for shared mobile data connectivity services by allocating the SIM cards remotely and dynamically to users. Ucloudlink's core business is to provide mobile data connectivity services at competitive prices, which it delivers through a range of hardware products and service solutions to its business partners, retail, and enterprise customers. The main hardware terminals offered by the company include portable Wi-Fi terminals, smartphones, and smart-hardware products for international and local mobile data connectivity services. Geographically, it generates maximum revenue from Japan.

Share on Social Networks: